T. Rowe Price Capital Appreciation Fund (PRWCX)
Ticker Symbol:
PRWCX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 30, 2014 at 4pm EST
Fund Composition
Asset Allocation
as of 09/30/2017
Domestic Stock 58.7%
Domestic Bond 19.3%
Cash 12.9%
Foreign Stock 4.0%
Convertibles 2.6%
Foreign Bonds 2.2%
Preferreds 0.7%
Other 0.1%
Options -0.5%
Volatility and Other Measures
as of 09/30/2017
Beta 0.62
0.89
Standard Deviation 6.47
Price/Earnings Ratio (Domestic) 20.5
Earnings Growth Rate (Domestic) 11
Turnover Rate 36.9
Median Market
Capitalization
$45,171.39 Million
Sector Diversification
as of 09/30/2017
% of Total Net Assets
Health Care 16.9%
Information Technology 13.4%
Consumer Discretionary 9.7%
Financials 7.7%
Consumer Staples 6.0%
Industrials & Business Services 4.9%
Utilities 2.6%
Real Estate 2.1%
Energy 1.3%
Materials 0.6%
10 Largest Holdings
Represents 25.68 % of Total Net Assets
View Holdings as of:
Abbott Laboratories
Alphabet
Bank of New York Mellon
Becton, Dickinson & Company
Danaher
Fiserv
Marsh & McLennan
Microsoft
PerkinElmer
Visa
As of 09/30/2017 the Capital Appreciation Fund had a total of 284 holdings.
See Glossary for additional details on all data elements.